Results
|
|
1.
|
Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes. MedStar authors:
Year: 2015
Citation: - American Journal of Obstetrics & Gynecology. 213(4):560.e1-8, 2015 Oct.
Institution: - MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology, Maternal-Fetal Medicine
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Caritis SN, Carpenter MW, Catalano P, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Landon MB, Mele L, Palatnik A, Ramin SM, Reddy UM, Rouse DJ, Saade GR, Sciscione A, Sorokin Y, Thorp JM Jr, Varner MW, Wapner RJ
|
|
|
2.
|
Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care. MedStar authors:
- Magee, Michelle
- Montero, Alex R
- Nassar, Carine M
- Youssef, Gretchen A
Year: 2021
Citation: - BMC Endocrine Disorders. 21(1):222, 2021 Nov 10.
Institution:
- MedStar Diabetes Institute
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Gann K, Magee MF, Montero AR, Nassar CM, Toro-Tobon D, Youssef GA
|
|
|
3.
|
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors:
Year: 2017
Citation: - Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C
|
